“Las células linfoides innatas helper (hILC) son resistentes a la terapia inmunosupresora: una observación del trasplante renal y hepático”. Elena Gómez Massa (Servicio de Inmunología, Hospital 12 de Octubre).
This web site uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and accepting our cookies policy, click the link for more information.plugin cookies